Tbcrc-055: A Phase Ii Study Of Niraparib, Dostarlimab, And Radiotherapy In Metastatic, Pd-L1 Negative Or Immunotherapy-Refractory Triple-Negative Breast Cancer (Nadir) - Nct04837209
Dostarlimab;Niraparib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Tbcrc-055: A Phase Ii Study Of Niraparib, Dostarlimab, And Radiotherapy In Metastatic, Pd-L1 Negative Or Immunotherapy-Refractory Triple-Negative Breast Cancer (Nadir) - Nct04837209 ### Output: Dostarlimab;Niraparib